Placebo Controlled Study of Preladenant in Participants With Moderate to Severe Parkinson's Disease (P07037)
Clinical trial NCT01227265 · COMPLETED
Trial details
- NCT number
- NCT01227265
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-11-19
- Primary completion
- 2013-04-04
- Enrollment
- 476
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.